When severe nerve pain turns the body's alarm system into an unceasing siren, can just five days of intravenous ketamine force the brain to unlearn the agony? We dive into a head-to-head clinical trial pitting ketamine against lidocaine to uncover how a rapid molecular circuit breaker delivers months of life-changing relief.

### Engaging Description

When severe neuropathic pain turns the nervous system into an unceasing alarm, conventional daily medications fail over half of all sufferers. In a head-to-head clinical trial, researchers pitted five consecutive days of intravenous ketamine directly against lidocaine to discover which could halt treatment-resistant nerve pain faster.

Ketamine emerged as an explosive sprinter, delivering clinically meaningful relief in over 86% of patients by week two compared to just 50% for lidocai ...